Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    April 2017
  1. LU Z, Zhang C, Sheng J, Shen J, et al
    T cell receptor beta-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.
    Int J Cancer. 2017 Apr 21. doi: 10.1002/ijc.30743.
    PubMed     Text format     Abstract available


    March 2017
  2. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Text format     Abstract available


    February 2017
  3. SUGASE T, Takahashi T, Serada S, Nakatsuka R, et al
    Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30666.
    PubMed     Text format     Abstract available


  4. JEHANNIN-LIGIER K, Belot A, Guizard AV, Bossard N, et al
    Incidence Trends for Potentially Human Papilloma Virus-Related and -Unrelated Head and Neck Cancers in France using Population-based Cancer Registries Data: 1980-2012.
    Int J Cancer. 2017 Feb 6. doi: 10.1002/ijc.30631.
    PubMed     Text format     Abstract available


    January 2017
  5. ANANTHARAMAN D, Abedi-Ardekani B, Beachler DC, Gheit T, et al
    Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30608.
    PubMed     Text format     Abstract available


    December 2016
  6. HATANO T, Sano D, Takahashi H, Hyakusoku H, et al
    Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30589.
    PubMed     Text format     Abstract available


    November 2016
  7. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Text format     Abstract available


    October 2016
  8. MAO L, Deng WW, Yu GT, Bu LL, et al
    Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Int J Cancer. 2016 Oct 31. doi: 10.1002/ijc.30493.
    PubMed     Text format     Abstract available


  9. CHEN X, Yuan Z, Lu M, Zhang Y, et al
    Poor oral health is associated with an increased risk of esophageal squamous cell carcinoma - a population-based case-control study in China.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30484.
    PubMed     Text format     Abstract available


    September 2016
  10. RAMAYANTI O, Juwana H, Verkuijlen SA, Adham M, et al
    Epstein-Barr Virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30418.
    PubMed     Text format     Abstract available


    August 2016
  11. LIU Z, Coghill AE, Pfeiffer RM, Hsu WL, et al
    Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30390.
    PubMed     Text format     Abstract available


    July 2016
  12. VON MASSENHAUSEN A, Sanders C, Bragelmann J, Konantz M, et al
    Targeting DDR2 in Head and Neck Squamous Cell Carcinoma with Dasatinib.
    Int J Cancer. 2016 Jul 19. doi: 10.1002/ijc.30279.
    PubMed     Text format     Abstract available


    June 2016
  13. QUAN H, Fang L, Pan H, Deng Z, et al
    An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
    Int J Cancer. 2016;138:2952-62.
    PubMed     Text format     Abstract available


  14. XIE SH, Lagergren J
    A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.
    Int J Cancer. 2016;138:2813-9.
    PubMed     Text format     Abstract available


    May 2016
  15. CHIN YM, Ping Tan L, Abdul Aziz N, Mushiroda T, et al
    Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort.
    Int J Cancer. 2016 May 28. doi: 10.1002/ijc.30207.
    PubMed     Text format     Abstract available


  16. LAPRISE C, Puthiyannal Shahul H, Arekunnath Madathil S, Soman Thekkepurakkal A, et al
    Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30201.
    PubMed     Text format     Abstract available


  17. YOUNG MR, Levingston CA, Johnson SD
    Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
    Int J Cancer. 2016;138:2487-98.
    PubMed     Text format     Abstract available


  18. WAGNER S, Wittekindt C, Reuschenbach M, Hennig B, et al
    CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;138:2263-73.
    PubMed     Text format     Abstract available


    March 2016
  19. TCHEANDJIEU C, Lesueur F, Sanchez M, Baron-Dubourdieu D, et al
    Fine-Mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30088.
    PubMed     Text format     Abstract available


  20. LIERSCH-LOHN B, Slavova N, Buhr HJ, Bennani-Baiti IM, et al
    Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Int J Cancer. 2016;138:1220-31.
    PubMed     Text format     Abstract available


  21. EK WE, Lagergren K, Cook M, Wu AH, et al
    Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Int J Cancer. 2016;138:1146-52.
    PubMed     Text format     Abstract available


  22. SHOULTZ-HENLEY S, Garden AS, Mohamed AS, Sheu T, et al
    Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation.
    Int J Cancer. 2016;138:1290-7.
    PubMed     Text format     Abstract available


  23. CRUMP C, Sundquist J, Sieh W, Winkleby MA, et al
    Fetal growth and subsequent maternal risk of thyroid cancer.
    Int J Cancer. 2016;138:1085-93.
    PubMed     Text format     Abstract available


  24. ZHU DD, Zhang J, Deng W, Yip YL, et al
    Significance of NF-kappaB activation in immortalization of nasopharyngeal epithelial cells.
    Int J Cancer. 2016;138:1175-85.
    PubMed     Text format     Abstract available


    February 2016
  25. UPRETI D, Zhang ML, Bykova E, Kung SK, et al
    Change in CD3zeta-chain expression is an independent predictor of disease status in Head and Neck Cancer Patients.
    Int J Cancer. 2016 Feb 16. doi: 10.1002/ijc.30046.
    PubMed     Text format     Abstract available


  26. NG HY, Ko JM, Yu VZ, Ip JC, et al
    DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
    Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30034.
    PubMed     Text format     Abstract available


  27. WANG HM, Cheng NM, Lee LY, Fang YH, et al
    Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Int J Cancer. 2016;138:731-8.
    PubMed     Text format     Abstract available


    January 2016
  28. VOJTECHOVA Z, Sabol I, Salakova M, Turek L, et al
    Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.
    Int J Cancer. 2016;138:386-95.
    PubMed     Text format     Abstract available


  29. GOROGH T, Quabius ES, Heidebrecht H, Nagy A, et al
    Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29986.
    PubMed     Text format     Abstract available


  30. HUI KF, Cheung AK, Choi CK, Yeung PL, et al
    Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Int J Cancer. 2016;138:125-36.
    PubMed     Text format     Abstract available


  31. WANGSA D, Chowdhury SA, Ryott M, Gertz EM, et al
    Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
    Int J Cancer. 2016;138:98-109.
    PubMed     Text format     Abstract available


  32. DRAHOS J, Xiao Q, Risch HA, Freedman ND, et al
    Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
    Int J Cancer. 2016;138:55-64.
    PubMed     Text format     Abstract available


    December 2015
  33. FRANCESCHI S, Combes JD, Dalstein V, Caudroy S, et al
    Deep brush-based cytology in tonsils resected for benign diseases.
    Int J Cancer. 2015;137:2994-9.
    PubMed     Text format     Abstract available


  34. CIRELLO V, Colombo C, Perrino M, De Leo S, et al
    Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the disease.
    Int J Cancer. 2015;137:2989-93.
    PubMed     Text format     Abstract available


  35. O'GRADY TJ, Gates MA, Boscoe FP
    Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
    Int J Cancer. 2015;137:2664-73.
    PubMed     Text format     Abstract available


    November 2015
  36. ZHANG F, Sturgis EM, Sun Y, Zhang Y, et al
    Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Int J Cancer. 2015;137:2454-61.
    PubMed     Text format     Abstract available


  37. BRAGANZA MZ, Potischman N, Park Y, Thompson FE, et al
    Adolescent and mid-life diet and subsequent risk of thyroid cancer in the NIH-AARP diet and health study.
    Int J Cancer. 2015;137:2413-23.
    PubMed     Text format     Abstract available


  38. HALEC G, Schmitt M, Egger S, Abnet CC, et al
    Mucosal Alpha-Papillomaviruses are not associated with Esophageal Squamous Cell Carcinomas: Lack of Mechanistic Evidence from South Africa, China and Iran and from a World-Wide Meta-Analysis.
    Int J Cancer. 2015 Nov 3. doi: 10.1002/ijc.29911.
    PubMed     Text format     Abstract available


    October 2015
  39. LIN W, Ren FM, Ren ZF
    The contribution of radiotherapy to subsequent thyroid cancer risk may be confined to a subgroup of breast cancer patients.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29907.
    PubMed     Text format    


  40. SUN LM, Lin CL, Liang JA, Kao CH, et al
    Authors' reply to Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29906.
    PubMed     Text format    


  41. MANCIKOVA V, Cruz R, Inglada-Perez L, Fernandez-Rozadilla C, et al
    Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.
    Int J Cancer. 2015;137:1870-8.
    PubMed     Text format     Abstract available


  42. ZHANG L, Huang X, Zhu X, Ge S, et al
    Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma.
    Int J Cancer. 2015 Oct 5. doi: 10.1002/ijc.29882.
    PubMed     Text format     Abstract available


    September 2015
  43. JING Z, Hou X, Liu Y, Yan S, et al
    Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies.
    Int J Cancer. 2015;137:1484-90.
    PubMed     Text format     Abstract available


  44. BO Y, Lu Y, Zhao Y, Zhao E, et al
    Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis.
    Int J Cancer. 2015 Sep 10. doi: 10.1002/ijc.29838.
    PubMed     Text format     Abstract available


  45. CHATENOUD L, Garavello W, Pagan E, Bertuccio P, et al
    Laryngeal cancer mortality trends in European countries.
    Int J Cancer. 2015 Sep 3. doi: 10.1002/ijc.29833.
    PubMed     Text format     Abstract available



  46. Erratum: Salt tea consumption and esophageal cancer: A possible role of alkaline beverages in esophageal carcinogenesis.
    Int J Cancer. 2015;137:E2-E8.
    PubMed     Text format    


  47. JIA Y, Wang H, Wang Y, Wang T, et al
    Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
    Int J Cancer. 2015;137:1095-106.
    PubMed     Text format     Abstract available


  48. GANDOLFI G, Sancisi V, Piana S, Ciarrocchi A, et al
    Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma.
    Int J Cancer. 2015;137:1001-11.
    PubMed     Text format     Abstract available


    August 2015
  49. LAPRISE C, Mathadil SA, Allison P, Abraham P, et al
    No role for human papillomavirus infection in oral cancers in a region in Southern India.
    Int J Cancer. 2015 Aug 28. doi: 10.1002/ijc.29827.
    PubMed     Text format     Abstract available


  50. KOSUMI K, Baba Y, Sakamoto A, Ishimoto T, et al
    Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.
    Int J Cancer. 2015 Aug 3. doi: 10.1002/ijc.29714.
    PubMed     Text format     Abstract available


  51. STEFFEN A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, et al
    General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2015;137:646-57.
    PubMed     Text format     Abstract available


  52. SIOLEK M, Cybulski C, Gasior-Perczak D, Kowalik A, et al
    CHEK2 mutations and the risk of papillary thyroid cancer.
    Int J Cancer. 2015;137:548-52.
    PubMed     Text format     Abstract available


  53. JANSSON C, Oh JK, Martinsen JI, Lagergren J, et al
    Occupation and risk of oesophageal adenocarcinoma and squamous-cell carcinoma: The Nordic Occupational Cancer Study.
    Int J Cancer. 2015;137:590-7.
    PubMed     Text format     Abstract available


  54. SCHULZ C, Kullmann F, Kunzmann V, Fuchs M, et al
    NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Int J Cancer. 2015;137:678-85.
    PubMed     Text format     Abstract available


    July 2015
  55. PHOON YP, Cheung AK, Cheung FM, Chan KF, et al
    IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-kappaB-mediated signalling.
    Int J Cancer. 2015 Jul 31. doi: 10.1002/ijc.29702.
    PubMed     Text format     Abstract available


  56. ZAMORA-ROS R, Rinaldi S, Tsilidis KK, Weiderpass E, et al
    Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2015 Jul 18. doi: 10.1002/ijc.29693.
    PubMed     Text format     Abstract available


  57. BALERMPAS P, Rodel F, Rodel C, Krause M, et al
    CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29683.
    PubMed     Text format     Abstract available


  58. DENT BM, Ogle LF, O'Donnell RL, Hayes N, et al
    High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29680.
    PubMed     Text format     Abstract available


  59. ODENTHAL M, Hee J, Gockel I, Sisic L, et al
    Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction.
    Int J Cancer. 2015;137:230-7.
    PubMed     Text format     Abstract available


  60. SUN LM, Lin CL, Liang JA, Huang WS, et al
    Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29667.
    PubMed     Text format     Abstract available


    June 2015
  61. WICHMANN G, Rosolowski M, Krohn K, Kreuz M, et al
    The role of HPV RNA transcription, immune response- related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Int J Cancer. 2015 Jun 20. doi: 10.1002/ijc.29649.
    PubMed     Text format     Abstract available


  62. FRANCESCHI S, Vaccarella S
    Thyroid cancer: an epidemic of disease or an epidemic of diagnosis?
    Int J Cancer. 2015;136:2738-9.
    PubMed     Text format    


  63. LA VECCHIA C, Bosetti C, Malvezzi M, Garavello W, et al
    Author's reply to thyroid cancer: an epidemic of disease or an epidemic of diagnosis?
    Int J Cancer. 2015;136:2740.
    PubMed     Text format    


    May 2015
  64. SAMMAN M, Wood HM, Conway C, Stead L, et al
    A novel genomic signature reclassifies an oral cancer subtype.
    Int J Cancer. 2015 May 26. doi: 10.1002/ijc.29615.
    PubMed     Text format     Abstract available


  65. BECKER C, Wilson JC, Jick SS, Meier CR, et al
    Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
    Int J Cancer. 2015 May 13. doi: 10.1002/ijc.29601.
    PubMed     Text format     Abstract available


    July 2014
  66. GIULIANO AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, et al
    EUROGIN 2014 roadmap: Differences in HPV infection natural history, transmission, and HPV-related cancer incidence by gender and anatomic site of infection.
    Int J Cancer. 2014 Jul 17. doi: 10.1002/ijc.29082.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: